Table 1: 2022/23 Director Attendance at Board and Committee meetings Board of Directors Audit and Risk Management Committee Human Resources and Remuneration Committee Innovation and Development Committee Corporate Governance and Nomination Committee A B A1 B A2 B A B A B B McNamee 9 9 7* 6* 4 4 5 5 B Brook 9 9 7 7 1* 4* 5 5 C Hewson 9 9 7 7 6 6 4* 5 5 M Clark 9 9 7* 6 6 4 4 5 5 A Cuthbertson 9 9 7* 6* 4 4 5 5 MMcDonald 9 9 7 7 6 6 4* D Maskell 9 9 6* 2* 4 4 A Watkins 9 9 7 7 6 6 4* P McKenzie3 5 5 4 2* P Perreault4 4 4 5* 4* 4 4* A Number of meetings held whilst a member. B N umber of meetings attended. Board Committee meetings are open to all directors to attend. Where a director attended a meeting of a committee of which they were not a member, it is indicated with an asterisk*. 1. One of the Audit and Risk Management Committee meetings was held jointly with the Human Resources and Remuneration Committee. 2. One of the Human Resources and Remuneration Committee meetings was held jointly with the Audit and Risk Management Committee. 3. Dr Paul McKenzie was appointed to the CSL Board on 13 December 2022. 4. Mr Paul Perreault retired from the CSL Board effective 5 March 2023. 6. Dividends On 14 August 2023, the directors resolved to pay a final dividend of US$1.29 per ordinary share to be paid on 4 October 2023, 10% franked, bringing dividends per share in respect of the 2023 financial year to US$2.36 per share. In accordance with determinations by the directors, CSL does not operate a dividend investment plan. Dividends paid during the year were as follows: Dividend Date paid Franking per share Amount per share US$ Total dividend US$ Final dividend for year ended 30 June 2022 05 October 2022 10% franked at 30% tax rate 1.18 cents $569m Interim dividend for year ended 31 December 2022 05 April 2023 Unfranked 1.07 cents $516m Dividends are determined after period-end and announced with the results for the period. Interim dividends are typically determined in February and paid in April. Final dividends are typically determined in August and paid in October. Dividends determined but not yet paid are not recorded as a liability at the end of the period to which they relate. 7. Developments in operations in future years and expected results The OFR sets out information on CSL’s business strategies and prospects for future financial years and refers to likely developments in CSL’s operations and the expected results of those operations in future financial years. Certain information is excluded because it is likely to result in material detriment or unreasonable prejudice to the Group. 8. Significant changes and subsequent events CEO Transition On 13 December 2022, CSL announced the appointment of Dr Paul McKenzie as Managing Director and Chief Executive Officer of CSL with effect from 6 March 2022, upon the retirement of Mr Paul Perreault. CSL Vifor acquisition On 9 August 2022, CSL completed the acquisition of CSL Vifor. See Note 2 (Business Combination) and Note 11 (Financial Risk Management) of the Financial Statements for further details. Other than as disclosed in the Directors’ Report (which includes the OFR) and information as disclosed in Note 24 (Subsequent Events) of the Financial Statements, the directors are not aware of: • any significant changes in the consolidated entity’s state of affairs during the year or to the Group’s principal activities during the year; or • any other matter or circumstance which has arisen since the end of the financial year which has significantly affected or may significantly affect the operations of the Group, results of those operations or the state of affairs of the Group in subsequent financial years. CSL Limited Annual Report 2022/23 77
RkJQdWJsaXNoZXIy MjE2NDg3